CD8A and breast cancer: COSMC KO of human breast cancer cells actually sensitized tumor cells to natural killer or cytotoxic CD8+ T cell killing (67), while sialyl-T was shown to promote the differentiation of tumor-associated macrophages through the engagement of inhibitory sialic acid-binding receptor Siglec-9, respectively (68).